Nuclear imaging market set for steady growth at 3.87% CAGR from 2024 to 2032, fueled by rising chronic disease prevalence and AI-driven innovations. Akash Anand SNS Insider Pvt. Ltd 415-230-0044 email ...
Lantheus' oncology portfolio includes Pylarify (piflufolastat F 18) and a growing pipeline addressing various solid tumours.
Researchers at the Accelerator Laboratory of the University of Jyväskylä, Finland, precisely measured atomic masses of ...
Located at the Precision Nuclear Oncology and Theranostics facility in Rustenburg, North West Province, this PET-CT scanner ...
Positron is committed to expanding the cardiac and oncology PET modality by delivering the best technology and value to ...
Two new PET radiotracers have outperformed the only currently Food and Drug Administration (FDA) approved radiotracer for detecting tau tangles in the brain, a hallmark of Alzheimer’s disease. In a ...
News Medical on MSN4d
New procedure standard/practice guideline issued for fibroblast activation protein PETThe Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the European Association of Nuclear Medicine (EANM) have ...
HAZARD, Ky. (WYMT) - Hazard Community and Technical College (HCTC) announced a new program. In the fall, the college will ...
Y-mAbs Therapeutics (YMAB) announced the presentation of preclinical and translational pharmacokinetics data of GD2-SADA in a poster at the ...
The poster titled “ Preclinical and Translational Pharmacokinetics of GD2-SADA, a Self-Assembling and Disassembling (SADA) Bispecific Fusion Protein for Pretargeted Radioimmunotherapy (PRIT)” ...
(HealthDay News) — Appropriate use criteria (AUC) for the use of amyloid and tau positron emission tomography (PET) have been issued by the Alzheimer’s Association and the Society for Nuclear Medicine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback